You are here: Industry Insights > Stempeutics

News List

Stempeutics’ allogeneic cell therapy gets DCGI approval, Cipla to market and distribute Stempeucel expresspharma
August 21, 2020
Indicated for the treatment of CLI due to Buerger’s Disease and Atherosclerotic Peripheral Arterial Disease, it is the first allogeneic cell therapy product to be approved for commercial use in India.
Stempeutics India and Novumcella Japan to work on development co-operation of Stempeucel product for expresspharma
June 02, 2020
As per the agreement, Novumcella will initially provide regulatory support services to Stempeutics for getting approval from Pharmaceuticals and Medical Devices Agency.
Stempeutics partners with Kemwell for global development and commercialisation of stem cell… expresspharma
July 30, 2019
Stempeutics Research has announced that it has signed a strategic deal with Kemwell Biopharma for global commercialisation of its stem cell product Stempeucel.
Stempeutics partners with Cipla financialexpress
May 21, 2018
Biotech firm Stempeutics Research has inked an out-licensing deal with drug major Cipla for its stem cell therapy product Stempeucel, indicated for treating critical limb ischemia. “